Somalogic Inc
F:76X0

Watchlist Manager
Somalogic Inc Logo
Somalogic Inc
F:76X0
Watchlist
Price: 1.93 EUR -3.5% Market Closed
Market Cap: €364.2m

Net Margin

-187.6%
Current
Declining
by 37.8%
vs 3-y average of -149.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-187.6%
=
Net Income
$-130.4m
/
Revenue
$81.7m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-187.6%
=
Net Income
€-130.4m
/
Revenue
$81.7m

Peer Comparison

Country Company Market Cap Net
Margin
US
Somalogic Inc
F:76X0
364.2m EUR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
160.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.9B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.1B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 15 072 companies
12th percentile
-187.6%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Somalogic Inc
Glance View

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in New York City, New York and currently employs 320 full-time employees. The company went IPO on 2021-02-23. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaSignal Tests, SomaScan Panels, and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. SomaSignal Tests are available as laboratory developed tests (LDT) for use in obtaining proteomics information from patients and monitoring patients’ physiological states, among others. SomaScan Panels consists of two categories: fixed panels and custom panels. The company offers drug development, analysis of clinical trial and new human biology insights.

76X0 Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-187.6%
=
Net Income
$-130.4m
/
Revenue
$81.7m
What is Somalogic Inc's current Net Margin?

The current Net Margin for Somalogic Inc is -187.6%, which is below its 3-year median of -149.8%.

How has Net Margin changed over time?

Over the last 3 years, Somalogic Inc’s Net Margin has decreased from -115.9% to -187.6%. During this period, it reached a low of -168.7% on Oct 30, 2023 and a high of -57.3% on Jun 30, 2021.

Back to Top